Navigation Links
Par Pharmaceutical Reports Second Quarter 2008 Results
Date:8/7/2008

ED CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share Data)

(Unaudited)

June 28, December 31,

2008 2007

ASSETS

Current assets:

Cash and cash equivalents $177,656 $200,132

Available for sale debt and marketable

equity securities 115,306 85,375

Accounts receivable, net 61,284 64,182

Inventories 51,774 84,887

Prepaid expenses and other current assets 15,684 14,294

Deferred income tax assets 54,868 56,921

Income taxes receivable 21,715 17,516

Total current assets 498,287 523,307

Property, plant and equipment, at cost less

accumulated depreciation and amortization 84,771 82,650

Available for sale debt and marketable

equity securities 5,156 6,690

Investment in joint venture - 6,314

Other investments 2,500 2,500

Intangible assets, net 55,350 36,059

Goodwill 63,729 63,729

Deferred financing costs and other assets 2,085 2,544

Non-current deferred income tax assets, net 59,252 57,730

Total assets $771,130 $781,523

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Current portion of long-term debt $200,000 $200,000

Accounts payable
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Memory Pharmaceuticals to Announce Second Quarter 2008 Results on Wednesday, August 13, 2008
3. Watson Pharmaceuticals Reports Second Quarter 2008 Results
4. XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies
5. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
6. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
7. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
8. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
10. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
11. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Regenestem Network has announced the grand ... Aires, Argentina. The clinic will be lead by Silvina ... assembled a multidisciplinary team of medical professionals who specialize ... Madero office. , The new Regenestem Network members ... studies in cellular therapies, and establish Regenestem protocols to ...
(Date:5/26/2015)... and HILDEN, Germany , May ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... Clinical Insight ® (QCI™) bioinformatics content and ... and report on genomic variants identified in next-generation ... the bioinformatics platform are in oncology, for somatic ...
(Date:5/26/2015)... 26, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... Company,s Annual Meeting of Shareholders for fiscal year ended ... at the Company,s office located in Chengdu, ... AM (local time in Chengdu, China ...
(Date:5/26/2015)... WORTH, Texas , May 26, 2015  A ... Texas Health Science Center to detect early Alzheimer,s disease ... older adults. Detailed standardized guidelines that are ... practice have been published in Alzheimer,s & Dementia ... efforts of an international working group that includes UNT ...
Breaking Biology Technology:Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2
... LONDON, June 18 , ... Rights , Speciality European Pharma ... is pleased to announce that it will obtain,the exclusive ... Ireland, as of the 1st July 2009. Regurin, owned ...
... Johnson & Johnson (NYSE: JNJ ) today announced ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with ... (Nasdaq: CGRB ). , ... Merger Sub, Inc., initiated a cash tender offer to purchase ...
... , ... More Seed Options in the Marketplace. , ... Des Moines, Iowa, and Atlanta, Ind. (Vocus) June 17, 2009 –- Pioneer ... have entered into research and distribution agreements to bring additional corn and soybean products to ...
Cached Biology Technology:SEP Signs REGURIN(R) Deal 2SEP Signs REGURIN(R) Deal 3SEP Signs REGURIN(R) Deal 4SEP Signs REGURIN(R) Deal 5SEP Signs REGURIN(R) Deal 6Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology 2Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology 3Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements 2Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements 3
(Date:5/27/2015)...   Codonics (codonics.com), a global ... documentation solutions and Omnicell  (omnicell.com), a ... is pleased to announce their state of ... System® (SLS), an award-winning FDA class 2 ... Anesthesia Workstation, helps prevent medication errors, streamlines ...
(Date:5/26/2015)... May 26, 2015 Research ... addition of the "Saudi Arabia Biometric Systems ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric ... is projected to grow at over 22% ... is attributed to the surging demand for better ...
(Date:5/25/2015)...  Australia,s market for wearable technologies is considered to ... advent of several trials and prototypes. The release of ... to ignite interest in wearables as well as accelerate ... . This in turn will spur greater innovation from ... amongst vendors and distributors. Photo - ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4
... Last week, at the fourth annual Clinical Trials in ... Biostatistics and Data Management at Aeras Global TB Vaccine Foundation, and ... of the application of the latest in clinical data technology to ... The presentation provided an update on how effective technology can be ...
... is available in Spanish . , Deworming lambs ... eye color, according to an Agricultural Research Service (ARS) study. ... Small Farms Research Center in Booneville, Ark., and colleagues made ... veterinarians, and extension agents from the Southern Consortium for Small ...
... National Jewish Health have discovered a trigger that induces B ... immune response. They found that a molecule that binds toll-like ... and shifts it to a more effective, IgG form. , ... issue of the Journal of Experimental Medicine , support ...
Cached Biology News:Pioneering Use of Mobile Technology to Conduct Clinical Trials in Emerging Economies 2Pioneering Use of Mobile Technology to Conduct Clinical Trials in Emerging Economies 3For lambs, a pasture a week keeps blood suckers away 2Researchers discover trigger to early, effective antibody response 2Researchers discover trigger to early, effective antibody response 3
Secure-Seal™ hybridization chamber gasket, eight chambers, 9 mm diameter, 0.8 mm deep *set of 20*...
Recombinant Rat CINC-2 beta, CF...
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
SHEEP ANTI FLECAINIDE...
Biology Products: